Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical Ltd has announced the quotation of 56,250 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code 4DX, following the exercise of options or conversion of other convertible securities. This move is expected to enhance the company’s liquidity and potentially attract more investors, reinforcing its position in the medical imaging sector.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging products, which aim to improve the diagnosis and treatment of lung diseases.
Average Trading Volume: 6,041,673
Technical Sentiment Signal: Buy
Current Market Cap: A$752.1M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.